Crawley J N, Marangos P J, Stivers J, Goodwin F K
Neuropharmacology. 1982 Jan;21(1):85-9. doi: 10.1016/0028-3908(82)90216-7.
Clonazepam and chlordiazepoxide were administered chronically in increasing doses for three weeks in two different strains of mice. Forebrain [3H]diazepam binding was assayed in groups of mice sacrificed at 2, 26, 50 hr and 10 days following the last dose. Scatchard and single point analyses revealed a significant decrease in the number of [3H]diazepam binding sites [Bmax] which persisted for at least two days following chronic clonazepam treatment. The Bmax changes observed following chlordiazepoxide treatment were less pronounced than those elicited by clonazepam. No significant changes in receptor binding affinity (Kd) were detected with either drug. In the clonazepam-treated animals, Bmax values returned to normal by day 10 after drug treatment. Chronic benzodiazepine administration therefore induced a decrease in the apparent number of benzodiazepine binding sites in the mouse forebrain. The magnitude and duration of the observed subsensitivity appears to depend on the potency of the administered benzodiazepine.
在两种不同品系的小鼠中,以递增剂量长期给予氯硝西泮和氯氮䓬三周。在末次给药后2小时、26小时、50小时和10天处死的小鼠组中测定前脑[³H]地西泮结合。Scatchard分析和单点分析显示,慢性氯硝西泮治疗后,[³H]地西泮结合位点数量[Bmax]显著减少,且至少持续两天。氯氮䓬治疗后观察到的Bmax变化不如氯硝西泮引起的明显。两种药物均未检测到受体结合亲和力(Kd)的显著变化。在氯硝西泮治疗的动物中,药物治疗后第10天Bmax值恢复正常。因此,长期给予苯二氮䓬类药物会导致小鼠前脑苯二氮䓬结合位点的表观数量减少。观察到的敏感性降低的程度和持续时间似乎取决于所给予苯二氮䓬类药物的效力。